NPs Basic Information

Name
(1R,2S,12R,15S)-12-(2-hydroxypropan-2-yl)-7-methoxy-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-1,2-diol
Molecular Formula C21H29N3O4
IUPAC Name*
(1R,2S,12R,15S)-12-(2-hydroxypropan-2-yl)-7-methoxy-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-1,2-diol
SMILES
CC(C)([C@H]1C2=C([C@@H]([C@]3(N1C[C@@H]4CCCN4C3)O)O)C5=C(N2)C=C(C=C5)OC)O
InChI
InChI=1S/C21H29N3O4/c1-20(2,26)18-17-16(14-7-6-13(28-3)9-15(14)22-17)19(25)21(27)11-23-8-4-5-12(23)10-24(18)21/h6-7,9,12,18-19,22,25-27H,4-5,8,10-11H2,1-3H3/t12-,18+,19-,21+/m0/s1
InChIKey
RIXDFYAJYWMUMR-SFMXACBGSA-N
Synonyms
CHEMBL1090129
CAS NA
PubChem CID 46885581
ChEMBL ID CHEMBL1090129
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Indoles and derivatives
        • Subclass: Pyridoindoles
          • Direct Parent: Beta carbolines

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 387.5 ALogp: 0.4
HBD: 4 HBA: 6
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 92.2 Aromatic Rings: 5
Heavy Atoms: 28 QED Weighted: 0.63

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.309 MDCK Permeability: 0.00001030
Pgp-inhibitor: 0.496 Pgp-substrate: 0.992
Human Intestinal Absorption (HIA): 0.047 20% Bioavailability (F20%): 0.717
30% Bioavailability (F30%): 0.682

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.403 Plasma Protein Binding (PPB): 49.56%
Volume Distribution (VD): 3.031 Fu: 50.22%

ADMET: Metabolism

CYP1A2-inhibitor: 0.017 CYP1A2-substrate: 0.104
CYP2C19-inhibitor: 0.055 CYP2C19-substrate: 0.889
CYP2C9-inhibitor: 0.021 CYP2C9-substrate: 0.317
CYP2D6-inhibitor: 0.135 CYP2D6-substrate: 0.662
CYP3A4-inhibitor: 0.031 CYP3A4-substrate: 0.913

ADMET: Excretion

Clearance (CL): 7.201 Half-life (T1/2): 0.524

ADMET: Toxicity

hERG Blockers: 0.534 Human Hepatotoxicity (H-HT): 0.915
Drug-inuced Liver Injury (DILI): 0.061 AMES Toxicity: 0.131
Rat Oral Acute Toxicity: 0.937 Maximum Recommended Daily Dose: 0.993
Skin Sensitization: 0.116 Carcinogencity: 0.843
Eye Corrosion: 0.003 Eye Irritation: 0.009
Respiratory Toxicity: 0.978
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003013 0.523 D09OBB 0.283
ENC003264 0.464 D03DDR 0.278
ENC001958 0.464 D0H4JM 0.275
ENC002846 0.456 D0J1ML 0.265
ENC003265 0.402 D0J4JM 0.263
ENC001060 0.377 D05GKD 0.260
ENC002274 0.377 D0P0RX 0.256
ENC002064 0.333 D01JGV 0.254
ENC001941 0.319 D0U7GP 0.254
ENC000837 0.318 D0G8NJ 0.253
*Note: the compound similarity was calculated by RDKIT.